A Study to Investigate the Food Effect on the Pharmacokinetics of Ensartinib Capsules in Chinese Healthy Volunteers.
The main objective of this study is to evaluate the Effect of Food on the Pharmacokinetics of Ensartinib Capsules.
Non-Small Cell Lung Cancer
DRUG: Ensartinib with fed or fasting
Peak plasma concentration (Cmax) of Ensartinib, The effect of food on Cmax after high fat diet and fasting Blood sampling over a 120 hour period post dose in all dosing sessions, pre-dose(30minute),30min,1,1.5,2,2.5,3,3.5,4,4.5,5,6,8,12,24,36,48,72,96,120hour|Area under the plasma concentration versus time curve (AUC) of Ensartinib, The effect of food on AUC after high fat diet and fasting Blood sampling over a 120 hour period post dose in all dosing sessions, pre-dose(30minute),30min,1,1.5,2,2.5,3,3.5,4,4.5,5,6,8,12,24,36,48,72,96,120hour|Time of maximum concentration（Tmax）of Ensartinib, The effect of food on Tmax after high fat diet and fasting Blood sampling over a 120 hour period post dose in all dosing sessions, pre-dose(30minute),30min,1,1.5,2,2.5,3,3.5,4,4.5,5,6,8,12,24,36,48,72,96,120hour|Half life（T1/2）of Ensartinib, The effect of food on T1/2 after high fat diet and fasting Blood sampling over a 120 hour period post dose in all dosing sessions, pre-dose(30minute),30min,1,1.5,2,2.5,3,3.5,4,4.5,5,6,8,12,24,36,48,72,96,120hour
Percentage of adverse events, Percentage of adverse events as assessed by CTCAE v4.0, From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 2 months
The main objective of this study is to evaluate the Effect of Food on the Pharmacokinetics of Ensartinib Capsules in Chinese Healthy Volunteers. In addition, the safety of Ensartinib Capsules in Chinese Healthy Volunteers who with High-fat meal or fasting state will also be evaluated.